Dudediligence.

Nexalin Technology, Inc

NXLNASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$36,031Sep ’24$27,179Dec ’24$41,015Mar ’25$70,588Jun ’25$18,149Sep ’25$171,895Dec ’25$14,950Mar ’26$12,161Jun ’26
Net income, by quarter
−$2.4MSep ’24−$2.8MDec ’24−$2.0MMar ’25−$1.6MJun ’25−$2.3MSep ’25−$2.4MDec ’25−$2.1MMar ’26−$2.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$144,065$1.3M$110,748$168,721$301,647
Gross profit$122,623$958,145$85,060$132,128$240,274
Operating income−$6.0M−$1.8M−$5.7M−$7.8M−$8.4M
Net income−$6.1M−$1.7M−$4.6M−$7.6M−$8.2M
Operating cash flow−$1.1M−$2.2M−$3.8M−$3.9M−$5.0M
Cash$661,778$162,743$580,230$574,485$654,783
Shares outstanding4.9M7.3M7.4M13.3M19.2M